SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
therapeutic 1,736 words KG: Nusinersen (Spinraza) 2026-03-23
kind:therapeuticsection:therapeuticsstate:published
Contents

Nusinersen (Spinraza)

💊 Therapeutic Info
NameNusinersen (Spinraza)
SummaryComprehensive overview of nusinersen (Spinraza), the first FDA-approved antisense oligonucleotide therapy for spinal muscular atrophy

Knowledge Graph

Related Hypotheses (8)

Phase-Separated Organelle Targeting
Score: 0.52Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53Stress Granule Phase Separation Modulators
Score: 0.49

Related Analyses (4)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedLipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedBlood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (1)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas